Rare diseases
Investigational molecules
Locations
Santariskiu G. 5, Vilniaus M. Sav., 08406 Vilnius, Lithuania
Inlita UAB in Vilnius, Lithuania specialises in clinical trials of conditions such as Sjogren's syndrome, Colitis ulcerative, Chronic spontaneous urticaria, Dry eye, and other specialisations. This site conducts important research.
Clinical trials currently enrolling participants at this site.
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
LithuaniaA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
LithuaniaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
LithuaniaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
LithuaniaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
LithuaniaStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
LithuaniaStudy on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis
LithuaniaEfficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study
LithuaniaStudy on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older
LithuaniaStudy on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
LithuaniaStudy Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines
LithuaniaStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
LithuaniaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
